argenx SE (ARGX.BR)

EUR 575.6

(1.34%)

Inventory Summary of argenx SE

  • argenx SE's latest annual inventory in 2023 was 281.12 Million EUR , up 23.11% from previous year.
  • argenx SE's latest quarterly inventory in 2024 Q2 was 326.46 Million EUR , down 0.0% from previous quarter.
  • argenx SE reported annual inventory of 228.35 Million USD in 2022, up 109.35% from previous year.
  • argenx SE reported annual inventory of 109.07 Million USD in 2021, up 331.93% from previous year.
  • argenx SE reported quarterly inventory of 326.46 Million EUR for 2024 Q2, down 0.0% from previous quarter.
  • argenx SE reported quarterly inventory of - USD for 2023 Q3, down -100.0% from previous quarter.

Annual Inventory Chart of argenx SE (2023 - 2010)

Historical Annual Inventory of argenx SE (2023 - 2010)

Year Inventory Inventory Growth
2023 281.12 Million EUR 23.11%
2022 228.35 Million USD 109.35%
2021 109.07 Million USD 331.93%
2020 25.25 Million EUR 2229.23%
2019 1.08 Million EUR 101054018719188.89%
2018 - EUR -100.0%
2017 2.00 EUR 200324867.16%
2016 - EUR -100.0%
2015 1.00 EUR -100.0%
2014 111.87 Thousand EUR -23.57%
2013 146.37 Thousand EUR 30.21%
2012 112.41 Thousand EUR 70.07%
2011 66.1 Thousand EUR 10424550.74%
2010 0.63 EUR 0.0%

Peer Inventory Comparison of argenx SE

Name Inventory Inventory Difference
Nicox S.A. - EUR -Infinity%
European Medical Solutions 14.35 Million EUR -1858.001%
FERMENTALG 6.8 Million EUR -4030.617%
BioSenic S.A. - EUR -Infinity%
Celyad Oncology SA 1.26 Million EUR -22211.886%
Hyloris Pharmaceuticals SA 1.00 EUR -28112976800.0%
Onward Medical N.V. 936 Thousand EUR -29935.232%
Oxurion NV 128 Thousand EUR -219532.632%
PHAXIAM Therapeutics S.A. 671 Thousand EUR -41797.134%
Financière de Tubize SA - EUR -Infinity%
UCB SA 1.03 Billion EUR 72.732%